Chronic Hypertension During the First Trimester of
Pregnancy: What is New About the Use of Angiotensin-
Converting Enzyme Inhibitors?

Lucas Soares Bezerra; Marcelo Antônio Oliveira Santos-Veloso; Sandro Gonçalves de Lima

Opinion

Chronic Hypertension During the First Trimester of Pregnancy: What is New About the Use of Angiotensin- Converting Enzyme Inhibitors?

Lucas Soares Bezerra¹*, Marcelo Antônio Oliveira Santos-Veloso¹ and Sandro Gonçalves de Lima^1,2

¹Maurício de Nassau University, Brazil

²Federal University of Pernambuco, Brazil

Corresponding Author

Received Date: February 15, 2019; Published Date: February 20, 2019

Abstract

Cardiovascular diseases are a major cause of maternal mortality and morbidity worldwide, including developed countries [1]. The first-line drug to treat hypertension in pregnant women is methyldopa, which is an α2-adrenergic agent that has shown maternal and fetal safety and efficacy. However, methyldopa is not effective in all cases, and sometimes it is important to consider other pharmacological agents [1,2].

Article Details

Citation

Bezerra LS, Santos-Veloso MAO, Lima SG. Chronic Hypertension During the First Trimester of Pregnancy: What is New About the Use of Angiotensin-Converting Enzyme Inhibitors?. W J Gynecol Women’s Health. 2(1): 2019 WJGWH.MS.ID.000526.